Global E-cigarette Market Weekly (1.15-1.21)

Industry Insight by 2FIRSTS
Jan.22.2024
Global E-cigarette Market Weekly (1.15-1.21)
In a challenging market, big cigarette brands are entering Japan, while Malaysia pushes for e-liquid regulation. Can Korea's e-cigarette market rise in 2024?

The "credit society" with airtight regulations, stringent production conditions, and advertisers who constantly switch channels make it challenging for new tobacco brands to enter the Japanese market. However, as small brands face entry barriers and believe in the vast market potential after the relaxation of zero nicotine restrictions, established brands have started to seize this opportunity and expand their distribution.

 

The Malaysian E-Cigarette Consumers Association has announced that they have shared the findings of the 2FIRSTS report with local consumers and will continue to advocate for local e-liquid regulations.

 

In 2023, multiple well-known disposable e-cigarette brands such as ELFBAR and VUSE have entered the South Korean market. Simultaneously, South Korean conglomerates are also actively establishing their presence in the e-cigarette industry. This series of developments has the potential to disrupt the existing landscape of the South Korean e-cigarette market. In light of these changes, the question arises: Can the South Korean e-cigarette market thrive in 2024?

 

On January 18th, a backbench debate took place in the British Parliament, allowing backbench MPs to raise local or national issues and receive responses from relevant government ministers. The debate focused on the regulation of e-cigarettes in the UK, the World Health Organization (WHO), and the contrasting views between the organization and the British government regarding e-cigarettes.

 

On January 18, 2024, 2FIRSTS and CNR News held a signing ceremony for the ESG projects in the vaping industry, accompanied by the release of the "2023 Global Vaping Industry ESG Development Report" at the CNR News headquarters in Beijing. The event was attended by Wu Gang, Deputy Editor-in-Chief of CNR News, Zhao Tong, Co-founder and CEO of 2FIRSTS, Hu Lishan, Senior Director of the Financial and Economic Department at CNR News, and Hou Yuhuan, Global Vice President and Executive Editor-in-Chief of 2FIRSTS.

 

Blu's former factory, Tianchang Group, experiences a 79% decrease in e-cigarette sales and plans to seek new customers to expand its customer base.

 

The U.S. Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) to SMOK, a manufacturer of 22 e-cigarette products. Please refer to the detailed list at the end of the article.

 

Guangdong Liwang New Energy Co., Ltd. received three institutional visits and highlighted its advantages and future plans in the lithium-ion battery business.

 

Vuse Go 800 is set to be widely available in South Korea, with distribution expanding to include 30,000 convenience stores and tobacco shops throughout the country.

 

SKE, a company specializing in electronic atomizer components, has announced its plan to establish an industrial park in Guangshui City, Hubei Province, with a total investment of 1 billion RMB.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14